T1D Trials: My 43-Year Journey Through Success & Failure

Diamyd and the Diagnode-3 trial sadly have failed. ⚠️ The DIAGNODE-3 trial results are in — and they're not what the T1D community was hoping for.

Diamyd Medical's GAD-alum vaccine trial has concluded, and today I'm breaking down exactly what happened, what the data actually says, and what this means for the future of Type 1 Diabetes research and treatment.

This isn't clickbait — this is a reality check on where we stand, backed by the official data.

🔬 In this video:
- What DIAGNODE-3 was designed to do
- What the results actually showed
- Why this outcome matters for the broader T1D vaccine pipeline
- What comes next for the community

I've lived with Type 1 Diabetes for 43 years. I follow every serious step forward — and every setback — so you don't have to dig through the science alone.

💬 Drop your thoughts in the comments. How do you feel about this result?

🔔 Subscribe for real T1D science — no hype, no scams, just facts.
Get vidIQ to grow your channel faster! 🚀
https://vidiq.com/Type1Diabeticwar

Видео T1D Trials: My 43-Year Journey Through Success & Failure канала Type-1 Diabetic Warriors